Does Rallies track congressional trades in MDT?

Yes. Rallies tracks politician and congressional stock disclosures for MDT, including reported purchases, sales, dates, owners, and trade amounts when available.

Is MDT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MDT. It does not provide personalized investment advice.

MDT (Medtronic) Stock Analysis - Politician Trades

Medtronic (MDT) is a publicly traded Healthcare sector company. As of May 20, 2026, MDT trades at $77.75 with a market cap of $99.27B and a P/E ratio of 21.02. MDT moved -0.65% today. Year to date, MDT is -18.19%; over the trailing twelve months it is -9.65%. Its 52-week range spans $74.40 to $106.33. Analyst consensus is buy with an average price target of $105.58. Rallies surfaces MDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded MDT stock?

Recent politician trading activity in MDT includes disclosures from Julie Johnson, Julie Johnson, Rich McCormick, Rob Bresnahan, and Bruce Westerman. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

MDT Key Metrics

Key financial metrics for MDT
Metric	Value
Price	$77.75
Market Cap	$99.27B
P/E Ratio	21.02
EPS	$3.72
Dividend Yield	0.71%
52-Week High	$106.33
52-Week Low	$74.40
Volume	7.66M
Avg Volume	0
Revenue (TTM)	$34.76B
Net Income	$4.79B
Gross Margin	65.51%

Congressional Trades in MDT

Julie Johnson sale MDT on Dec 18, 2025 (amount: $15.00K) for Joint.
Julie Johnson sale MDT on Nov 13, 2025 (amount: $15.00K) for Joint.
Rich McCormick purchase MDT on Nov 5, 2025 (amount: $15.00K).
Rob Bresnahan purchase MDT on May 15, 2025 (amount: $15.00K).
Bruce Westerman sale MDT on Mar 20, 2025 (amount: $15.00K).

Latest MDT News

Medtronic falls 3% as MiniMed insulin pump recalls weigh; shares hit 52-week low — Apr 29, 2026
Medtronic Acquires CathWorks for $585M, Expands AI-Driven FFRangio System — Apr 29, 2026
Medtronic’s Stealth AXiS Secures CE Mark for Spine, Cranial Robotics — Apr 28, 2026
Medtronic says cybersecurity breach contained, no disruption to products or finances — Apr 27, 2026
Medtronic’s Target Slashed to $95 as Perfusion Market Eyes $2.4B by 2034 — Apr 23, 2026

Recent MDT Insider Trades

KIIL HARRY SKIP sold 1.65K (~$161.27K) on Feb 19, 2026.
KIIL HARRY SKIP sold 30.57K (~$2.99M) on Feb 19, 2026.
KIIL HARRY SKIP sold 19.25K (~$1.88M) on Feb 19, 2026.

MDT Analyst Consensus

20 analysts cover MDT: 0 strong buy, 12 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $105.58.

Common questions about MDT

Which politicians traded MDT stock?: Recent politician trading activity in MDT includes disclosures from Julie Johnson, Julie Johnson, Rich McCormick, Rob Bresnahan, and Bruce Westerman. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in MDT?: Yes. Rallies tracks politician and congressional stock disclosures for MDT, including reported purchases, sales, dates, owners, and trade amounts when available.
Is MDT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MDT. It does not provide personalized investment advice.